PEN (Penumbra, Inc.) Stock Analysis - Politician Trades

Penumbra, Inc. (PEN) is a publicly traded Healthcare sector company. As of May 20, 2026, PEN trades at $327.39 with a market cap of $12.84B and a P/E ratio of 74.72. PEN moved +0.24% today. Year to date, PEN is +3.93%; over the trailing twelve months it is +16.45%. Its 52-week range spans $186.97 to $362.41. Analyst consensus is neutral with an average price target of $353.00. Rallies surfaces PEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded PEN stock?

Rallies tracks politician and congressional stock disclosures for PEN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

PEN Key Metrics

Key financial metrics for PEN
MetricValue
Price$327.39
Market Cap$12.84B
P/E Ratio74.72
EPS$4.38
Dividend Yield0.00%
52-Week High$362.41
52-Week Low$186.97
Volume367.59K
Avg Volume0
Revenue (TTM)$1.45B
Net Income$171.05M
Gross Margin67.39%

Latest PEN News

Recent PEN Insider Trades

  • Grewal Harpreet sold 100 (~$32.82K) on Apr 2, 2026.
  • Yuen Maggie sold 2.43K (~$832.47K) on Mar 2, 2026.
  • Grewal Harpreet sold 186 (~$58.15K) on Jan 6, 2026.

PEN Analyst Consensus

5 analysts cover PEN: 0 strong buy, 1 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $353.00.

Common questions about PEN

Which politicians traded PEN stock?
Rallies tracks politician and congressional stock disclosures for PEN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in PEN?
Yes. Rallies tracks politician and congressional stock disclosures for PEN, including reported purchases, sales, dates, owners, and trade amounts when available.
Is PEN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PEN. It does not provide personalized investment advice.
PEN

PEN